COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 147 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $474,491 | +41.3% | 21,230 | +46.6% | 0.01% | +25.0% |
| Q4 2022 | $335,866 | -26.0% | 14,477 | -48.9% | 0.00% | -20.0% |
| Q3 2022 | $454,000 | -94.4% | 28,320 | -93.8% | 0.01% | -94.0% |
| Q2 2022 | $8,156,000 | +37.5% | 460,243 | +58.0% | 0.08% | +68.0% |
| Q1 2022 | $5,930,000 | -2.0% | 291,254 | -10.1% | 0.05% | +11.1% |
| Q4 2021 | $6,050,000 | +74.6% | 323,886 | +84.5% | 0.04% | +73.1% |
| Q3 2021 | $3,465,000 | +11848.3% | 175,509 | +12251.1% | 0.03% | – |
| Q4 2019 | $29,000 | +3.6% | 1,421 | -42.7% | 0.00% | – |
| Q3 2019 | $28,000 | +47.4% | 2,481 | +69.0% | 0.00% | – |
| Q2 2019 | $19,000 | +11.8% | 1,468 | +34.1% | 0.00% | – |
| Q1 2019 | $17,000 | -99.5% | 1,095 | -99.2% | 0.00% | -100.0% |
| Q2 2018 | $3,291,000 | -24.2% | 138,000 | -18.8% | 0.02% | -23.3% |
| Q1 2018 | $4,344,000 | +71.8% | 170,000 | +24.1% | 0.03% | +76.5% |
| Q4 2017 | $2,529,000 | – | 137,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |